(NYSE: INSP) Inspire Medical Systems's forecast annual revenue growth rate of 13.2% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.17%.
Inspire Medical Systems's revenue in 2026 is $882,622,000.On average, 21 Wall Street analysts forecast INSP's revenue for 2026 to be $29,840,957,718, with the lowest INSP revenue forecast at $28,412,543,423, and the highest INSP revenue forecast at $32,368,867,476. On average, 19 Wall Street analysts forecast INSP's revenue for 2027 to be $33,473,011,968, with the lowest INSP revenue forecast at $31,003,215,078, and the highest INSP revenue forecast at $37,453,743,426.
In 2028, INSP is forecast to generate $37,250,348,388 in revenue, with the lowest revenue forecast at $33,560,181,270 and the highest revenue forecast at $40,649,951,166.